BioHarvest Sciences Inc. Common StockBHST

BioHarvest Sciences (NASDAQ: BHST) (FSE: 8MV) is an industrial plant cell culture company pioneering Botanical Synthesis, a patented non-GMO platform technology that produces high-value, plant-derived compounds without growing the plant itself. By combining proprietary plant cell biology, elicitation technologies, AI-driven development and industrial-scale bioreactors, the Company creates 'precision botanics' with enhanced potency, purity, consistency and commercial scalability. Backed by more than $100 million invested in its technology platform, 15 patents and multidisciplinary scientific capabilities, BioHarvest operates two complementary growth engines: a rapidly growing direct-to-consumer business and an expanding CDMO division serving.

bioharvest.com